| HOME >> BIOLOGY >> TECHNOLOGY |
Unmet needs in antivirals 229
Policies regarding conquered viral diseases 230
Future of polio vaccine 230
Policies concerning HPV vaccine for prevention of cervical cancer 231
HPV vaccine in developing countries 231
Future prospects of innovative approaches 232
US Government support of antiviral efforts 233
US Government support for R & D in avian influenza vaccines 233
US Government support for developing anti-bioterrorism agents 233
The European Union support of antiviral research 234
European Commission's research support for anti-HIV/AIDS programs 234
European Commission's support anti-influenza programs 235
Collaboration of biotechnology companies with big pharma 236
Strategies for marketing 236
13. Companies 237
Introduction 237
Top companies 237
Profiles of pharmaceutical companies 238
Profiles of antiviral companies 254
Profiles of viral vaccine companies 365
Collaborations 429
14. References 434
Table 1 1: A practical classification of viruses 19
Table 1 2: Vaccines vs therapeutics for viral diseases 24
Table 1 3: Historical landmarks in the development of antiviral therapies 25
Table 2 1: Classification of antivi
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |